Concepedia

Alfonso Quintás‐Cardama

AQ

96

Publications

8.1K

Citations

48

H-Index

2004

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

Memorial Sloan Kettering Cancer Center

University of Michigan

Mayo Clinic

Alfonso Quintás‐Cardama is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

2004–2017

96

Publications

96

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms

Alfonso Quintás‐Cardama, Kris Vaddi, Phillip Liu et al. · Blood · 2010 · 813 citations

Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera

Alfonso Quintás‐Cardama, Hagop M. Kantarjian, Taghi Manshouri et al. · Journal of Clinical Oncology · 2009 · 412 citations · Full text

Pleural Effusion in Patients With Chronic Myelogenous Leukemia Treated With Dasatinib After Imatinib Failure

Alfonso Quintás‐Cardama, Hagop M. Kantarjian, Susan O’Brien et al. · Journal of Clinical Oncology · 2007 · 388 citations

Mutant FLT3: A Direct Target of Sorafenib in Acute Myelogenous Leukemia

Weiguo Zhang, Marina Konopleva, Yue-Xi Shi et al. · JNCI Journal of the National Cancer Institute · 2008 · 338 citations · Full text

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

Hagop M. Kantarjian, Susan O’Brien, Elias Jabbour et al. · Blood · 2012 · 335 citations · Full text

Rows per page

1–5 of 96